Medicare AdvantageCoverageMedium impact
MA08.017m, Botulinum Toxin Agents
Independence Blue Cross·Neurology, Dermatology, Plastic Surgery +4 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA08.017m regarding Botulinum Toxin Agents has been updated as of October 1, 2025. This is a fresh policy change that may affect coverage criteria, prior authorization requirements, or billing procedures for botulinum toxin treatments under Medicare Advantage plans.
Action Required
Immediately: Review the complete MA08.017m Botulinum Toxin Agents policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation needs. Billing team should verify current procedures align with updated policy requirements for Medicare Advantage patients receiving botulinum toxin treatments.